Pharmafile Logo
Pharmafocus logo
Advanced Search

Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds

May 8, 2025
Research and Development AI, Corporate, Devices, EU Data Act, HCPs, Johnson & Johnson, Pharmacy, digital technology, survey

A global survey by Johnson & Johnson MedTech has revealed that a majority of Europeans are willing to share their …

News

Bristol Myers Squibb appoints Cari Gallman as executive vice president, general counsel and chief policy officer

May 8, 2025
Business Services, Legal, Research and Development Corporate, appointment, bristol myers squibb

Global biopharma company, Bristol Myers Squibb, has announced the appointment of Cari Gallman as executive vice president, general counsel and …

Appointment

Digital Control Room, a major pharma provider, wins King’s Award for Enterprise

May 7, 2025
Business Services, Medical Communications Digital Control Room, King's Award for Enterprise, Pharma services, Pharmacy, UK

Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online content, will receive a King’s …

News

ENA Respiratory appoints two strategic advisors to support leading project

May 7, 2025
Research and Development Ena Respiratory, Infections and infestations, Respirology, strategic adivsors

ENA Respiratory, focused on minimising the impact of viral respiratory infections, has announced the appointment of Kenny Simmen (pictured left) …

Appointment
trialy

Alchemab Therapeutics signs $415m licensing agreement for ALS programme with Eli Lilly

May 7, 2025
Mergers and Acquisitions Alchemab Therapeutics, Corporate, Eli Lilly and Company, Immunology, M&A, als, immunology, neurodegenerative conditions

Alchemab Therapeutics, an immunotherapy-focused biopharma company, has entered a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, its …

News

Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant

May 6, 2025
Mergers and Acquisitions (OTC & VMS), Clayton, Clayton Dubilier & Rice (CD&R), Corporate, M&A, Opella, Sanofi, agreement

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofi’s …

News

Genmab to submit FDA application for lymphoma therapy

May 2, 2025
Research and Development AbbVie, Biologics License Application, FDA, Genmab, Oncology, epcoritamab, lymphoma, therapeutics

Global biotechnology company Genmab plans to submit a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) …

News
researchers_credit_neusentis_pfizer

Ambitious plans for leading cancer research centre announced

May 2, 2025
Market & Product Development, Medical Communications, Research and Development Aviva Capital Partners (ACP), Institute of Cancer Research (ICR), London, London Cancer Hub, Oncology, Royal Marsden NHS Foundation Trust, Socius

Aviva Capital Partners (ACP), an infrastructure and real estate investor, and Socius, a mixed-use developer, have unveiled plans for a …

News

Clinigen announces executive appointments to drive growth and investor value

May 1, 2025
Business Services, Pharmaceutical Consultancy Services Clinigen, Keith Bryne, Nihad Hasagic, Pharma services, Pharmacy, appointment

Clinigen, the global pharmaceutical services group, has announced key leadership changes to accelerate its growth and strengthen its position in …

Appointment

Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector

May 1, 2025
Manufacturing Services, Manufacturing and Production, Research and Development CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing

Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its …

Appointment

Deadly cancers are being financially left behind, new research claims

May 1, 2025
Research and Development Jude, Oncology, UK, bladder cancer, cancer research, charitable funding

New research has revealed that some of the UK’s most deadly and prevalent cancers receive the least amount of charitable …

News

Neogap chosen for Innovate Nordics 2025 Acceleration Programme

May 1, 2025
Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy

Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …

News

Cervical cancer experts campaign to increase screening rates and save lives

April 30, 2025
Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening

A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …

News

Novo Nordisk Foundation expands ambitious Challenge Programme internationally 

April 30, 2025
Research and Development Challenge Programme, Denmark, Novo Nordisk, Pharmacy, international

The Novo Nordisk Foundation Challenge Programme, a leading open competition grant programme, invites researchers outside of Denmark to participate and …

News

Gifthealth appoints Chip Parkinson as CEO to lead next phase of growth

April 29, 2025
Business Services, Pharmaceutical Consultancy Services CEO, Gifthealth, Pharmacy, pharmacy care

Gifthealth, a technology-driven pharmacy care company, has appointed Chip Parkinson as its new chief executive officer. The move marks a …

Appointment

Ryan Smith appointed as global head of sales at Astoriom

April 29, 2025
Logistics & Distribution, Research and Development Astoriom, Pharmacy, appointment, sample storage solutions

Global R&D sample stability and biorepository storage company, Astoriom, has announced the appointment of Ryan Smith as global head of …

Appointment
europe-1395916_640

EU approval granted for rare kidney disease treatment

April 29, 2025
Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology

The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …

News
stethoscope_and_background_doctor

Study finds new test could better predict risk of heart disease

April 28, 2025
Research and Development Cardiology, Chalmers University of Technologyu, Harvard, cholesterol tests, cvd

A study by Harvard University, US, and Chalmers University of Technology, Sweden, has found that measuring a lipoprotein marker combination …

News
blood-75301_640

Sobi and Sanofi’s Foundation S renew partnership with World Federation of Hemophilia

April 28, 2025
Pharmacy sales & educational programmes, Sales and Marketing Haematology, Sanofi, World Federation of Hemophilia, bleeding disorder, sobi

Sobi and Sanofi, through its organisation Foundation S, have extended their partnership with the World Federation of Hemophilia (WFH) Humanitarian …

News

McDavid Stilwell appointed as CFO of CPTx

April 28, 2025
Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics

CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025